Spun off from biotech firm AgriVida last year, Woburn, Massachusetts-based IngredientWerks has filed patents covering the expression of myoglobin, leghemoglobin, and casein in genetically engineered corn crops.

It announced seed funding from Open Prairie and ARCH Venture Partners in February and is currently raising a series A round. Motif is a financial partner in the development program for myoglobin, and “has certain first access rights to commercialize it,” said Plavan.

Source: Molecular farming: IngredientWerks grows heme protein in corn at ‘unprecedented low cost’

By Grégory Maubon

Leading Innovation ++ on the Field ++ with a Purpose => I used AI in cultivated meat industry to optimize bioreactor design and to dramatically improve the efficiency and quality of production. I developed high quality 3D imagery process in a biotechnological startup to disrupt the drug discovery methods.

Comments are closed.